111 Capital’s Acadia Healthcare ACHC Stock Holding History

111 Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-11,986	Closed	-$363K	–	501
2025 Q1	$363K	Buy	+11,986	New	+$457K	0.07%	285

Other funds holding ACHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ABI

Abrams Bison Investments Bethesda, Maryland $2.31B AUM 40.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

111 Capital's ACHC Position: Q2 2025 in Review

111 Capital sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 11,986 shares — an estimated $363K sold.

111 Capital first reported a position in ACHC in Q1 2025 and held it in 1 quarter. The position peaked at $363K in Q1 2025. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.

111 Capital reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
111 Capital sold 11,986 Acadia Healthcare shares in Q2 2025, an estimated $363K.
111 Capital first reported a position in Acadia Healthcare in Q1 2025 and held it in 1 quarter.
111 Capital's Acadia Healthcare position peaked at $363K in Q1 2025.
293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.

Based on 111 Capital's 13F filing for Q2 2025, filed 21 Jul 2025.